Immune/Lymphatic System Archives

Immune/Lymphatic System

The Magnet® effect: Success in minimizing bloodstream infections

One hospital’s Magnet quest and several other factors came together to reduce the infection rate.

Chemotherapy and Biotherapy Drugs for Autoimmune Disease

New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.

Updated guidelines for managing occupational HIV exposure released

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations…

Is your wound-cleansing practice up to date?

Do you know how to choose-and correctlyuse-the appropriate agent to clean your patient’s wound?

Be prepared for poison ivy, oak, and sumac

The author clears up misconceptions and discusses treatment.

Do no harm

Our editor-in-chief tackles the issue of mandatory flu vaccination.

Soothing the sorrow of psoriasis

You can help patients suffering from this chronic skin disease.

FDA approves first anti-diarrheal drug for HIV/AIDS patients

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…

Helping patients survive sepsis

In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.

FDA approves Xeljanz for rheumatoid arthritis

On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…

Essential elements of a comprehensive sharps injury-prevention program

The steps outlined below can help facilities significantly reduce sharps injuries.

Preventing catheter-related bloodstream infections related to I.V. connectors

The author provides an overview of the issue and suggests some solutions.

The Magnet® effect: Success in minimizing bloodstream infections

One hospital’s Magnet quest and several other factors came together to reduce the infection rate.

Chemotherapy and Biotherapy Drugs for Autoimmune Disease

New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.

Updated guidelines for managing occupational HIV exposure released

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus…

Is your wound-cleansing practice up to date?

Do you know how to choose-and correctlyuse-the appropriate agent to clean your patient’s wound?

Be prepared for poison ivy, oak, and sumac

The author clears up misconceptions and discusses treatment.

Do no harm

Our editor-in-chief tackles the issue of mandatory flu vaccination.

Soothing the sorrow of psoriasis

You can help patients suffering from this chronic skin disease.

FDA approves first anti-diarrheal drug for HIV/AIDS patients

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients…

Helping patients survive sepsis

In its early stages, sepsis can be difficult to detect. Learn about the sometimes-subtle signs and symptoms.

FDA approves Xeljanz for rheumatoid arthritis

On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid…

Essential elements of a comprehensive sharps injury-prevention program

The steps outlined below can help facilities significantly reduce sharps injuries.

Preventing catheter-related bloodstream infections related to I.V. connectors

The author provides an overview of the issue and suggests some solutions.

Take this 4-question survey to be entered to win an Visa $50 gift card.

*Winner of the gift card will be drawn on December 31^st, 2024. The winner will be contacted by email. By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address, may be used to keep you informed about future products and services.

Immune/Lymphatic System

NurseLine Newsletter

Malpractice Poll

About

Contact

Podcasts